Lipid-lowering therapy can be considered with a 10-year PREVENT-ASCVD risk estimate of 3% to <5% (borderline) and should be considered for those at 5% to <10% (intermediate) 10-year risk. For ...

Heart health experts released new guidance to help identify early risk factors for heart disease that go beyond tracking ...

Also, for the first time, doctors are advised to test for two biomarkers in the blood that have been linked to increased risks of heart disease.

The test can help assess your lifetime risk for cardiovascular disease. That, along with earlier treatment for high ...

While attending a church picnic in 2022, Morristown resident John Rataiczak’s wife Melissa started “feeling funny.” Then she ...

Millions more adults should consider starting cholesterol-lowering medications earlier to reduce their risk of heart attack ...

The American College of Cardiology (ACC), the American Heart Association and nine other leading medical associations, today issued an updated guideline for the management of dyslipidemia-abnormal ...

The ACC and AHA released updated guidelines for the management of dyslipidemia to reduce risk for atherosclerotic cardiovascular disease.

Eleven medical organizations advised changes to preventive cardiac care that it says could markedly reduce heart attacks and ...